Drug combination raises survival rates in breast cancer cases ...

It?s the first time such improvement in overall survival has been seen in trials of first-line hormonal therapy for hormone-receptive metastatic breast cancer, the study authors said.

?We?re finding a lot of other ways of treating these estrogen-receptor-positive breast cancers that don?t include chemotherapy,? said co-author Dr. Julie Gralow, director of breast medical oncology at Seattle Cancer Care Alliance.

Such hormone-targeting therapy is a key focus in breast-cancer research, in part because it avoids the toxic effects of chemotherapy, Gralow said. However, she cautioned, these first results need to be repeated and verified by other researchers and may only apply to a subgroup of women with this type of breast cancer.

The report, from the University of Michigan-based research group SWOG, one of five cooperative groups that comprise the National Cancer Institute?s National Clinical Trials Network, was published Wednesday in the New England Journal of Medicine.

Article source: http://newsok.com/drug-combination-raises-survival-rates-in-breast-cancer-cases/article/3698264

Source: http://cancerkick.com/2012/08/05/drug-combination-raises-survival-rates-in-breast-cancer-cases/

nick carter sister recruiting rankings san onofre paula deen birth control recall nick carter leslie carter